IRIS

Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax / Zorzetto, F; Scalas, A; Longu, F; Isoni, Ma; Angelucci, E; Fozza, C. - In: MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES. - ISSN 2035-3006. - 16:1(2024), p. e2024011. [10.4084/MJHID.2024.011]

Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax

Fozza, C
2024-01-01
2024
Inglese
WOS:001137478000001
16
1
e2024011
2-s2.0-85182623741
Acute myeloid leukemia; Azacitidine; Hemophagocytic lymphohistiocytosis; Venetoclax
Zorzetto, F; Scalas, A; Longu, F; Isoni, Ma; Angelucci, E; Fozza, C
Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax / Zorzetto, F; Scalas, A; Longu, F; Isoni, Ma; Angelucci, E; Fozza, C. - In: MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES. - ISSN 2035-3006. - 16:1(2024), p. e2024011. [10.4084/MJHID.2024.011]
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
6
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/322869
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact